Existing medicines and new uses
Existing medicines and new uses
An overview of medicines repurposing, the challenges of generating evidence, and how actuarial analysis can support value‑based decision‑making.
An overview of medicines repurposing, the challenges of generating evidence, and how actuarial analysis can support value‑based decision‑making.
In his first blog of 2020, the Government Actuary reflects on the challenges and opportunities of a new year. Martin Clarke looks at how actuarial expertise has evolved, and he concludes the Government Actuary’s Department (GAD) has “a firm mission to learn, adapt and at times experiment.”
The work of the Government Actuary's Department is core to the Analysis Function because we offer impartial actuarial analysis to our government and private sector clients.
In many instances, it’s no longer enough to just look at the financials – the profits, dividends and returns on investment. Instead, people are increasingly considering how these returns have been earned.
The Government Actuary's Department (GAD) launches one of the largest single-entry recruitment campaigns it has ever run. It's part of a push to recruit and grow our organisation to meet the growing needs of our clientele.
Actuaries are financial risk professionals, and at the Government Actuary’s Department (GAD) we provide impartial actuarial analysis to government and public sector clients. Our expertise covers insurance, investment, modelling, quality assurance, data science, pensions and social security.
Integrated risk management requires pension schemes to look at risks in the round, rather than considering each individually. This is because the risks are related – for example, funding risk is likely to be linked to either investment risk or employer covenant risk.
Recent Comments